Oct 30 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS INC - SIGNED A COLLABORATION, DEVELOPMENT AND SUPPLY AGREEMENT WITH DR. REDDY'S LABORATORIES AND GLOBAL RESPONSE AID
* APPILI - AGREEMENTS TO ACCELERATE WORLDWIDE DEVELOPMENT, COMMERCIALIZATION OF AVIGAN TABLETS FOR POTENTIAL TREATMENT AND PREVENTION OF COVID-19
* APPILI THERAPEUTICS INC - DR. REDDY'S AND GRA WILL CONTINUE TO BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, COMMERCIALIZATION, OF AVIGAN
* APPILI - WILL BE RESPONSIBLE FOR US & CANADIAN CLINICAL TRIALS CONDUCTED & WILL RECEIVE PROFIT SHARE ON ALL US AND CANADIAN SALES FOR A SPECIFIED TERM